Unfortunately when NH speaks he seems to increase investor uncertainty by stressing the negatives, eg. supply chain problems, testing delays due to Covid in India, and possibility that LCI will launch their own versions of Adderall.
What I would like to hear is : When does he expect LCI to launch Sabril and what is the expected market when they do? When does he expect a launch of Adderall in Israel? What is the Isreali market and are they planning to launch in other European or Asian Countries? What are the Company's plan for Sequestox filing and future products using its technology? What is the status of the new manufacturing technology the company has develop?
I agree the fear of LCI loss is the only real danger to the bottom line at this time. I would hope he has a new distribution partner already lined up is and when that happens.
News 
Market Data 
Discover 
